Inventor · disambiguated record
Zuchun Zhao
Also filed as: ZHAO ZUCHUN
39 granted patents·13 pending applications·632 citations·filing 1995–2022
98Inventor score
Top patents by PatentIndex Score
52 records- 0196US7638541B25-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidineMETABOLEX INC·Filed 2007·Granted Dec 29, 2009·43 cites·2 claims
- 0296US6140351AOrtho-anthranilamide derivatives as anti-coagulantsBERLEX LAB·Filed 1998·Granted Oct 31, 2000·179 cites·50 claims
- 0394US6432947B1N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 1999·Granted Aug 13, 2002·89 cites·34 claims
- 0493US7432394B2Resolution of α-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylaminesMETABOLEX INC·Filed 2006·Granted Oct 7, 2008·12 cites·21 claims
- 0592US5849759ANaphthyl-substituted benzimidazole derivatives as anti-coagulantsBERLEX LAB·Filed 1995·Granted Dec 15, 1998·79 cites·14 claims
- 0691US8227495B22,4-disubsituted thiazoles and pharmaceutical compositions thereofCHEN XIN·Filed 2009·Granted Jul 24, 2012·13 cites·18 claims
- 0791US6380221B1Ortho-anthranilamide derivatives as anti-coagulantsBERLEX LAB·Filed 2000·Granted Apr 30, 2002·33 cites·5 claims
- 0890US7714131B2Process for the stereoselective preparation of (−)-halofenate and derivatives thereofMETABOLEX INC·Filed 2006·Granted May 11, 2010·9 cites·16 claims
- 0989US8288384B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2009·Granted Oct 16, 2012·9 cites·1 claims
- 1089US6624194B1Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemiaMETABOLEX INC·Filed 2000·Granted Sep 23, 2003·38 cites·17 claims
- 1189US6555537B2Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2000·Granted Apr 29, 2003·24 cites·3 claims
- 1288US6534509B1Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2000·Granted Mar 18, 2003·19 cites·4 claims
- 1386US8183381B2N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersMA JINGYUAN·Filed 2008·Granted May 22, 2012·13 cites·10 claims
- 1484US6350761B1Benzenamine derivatives as anti-coagulantsBERLEX LAB·Filed 2000·Granted Feb 26, 2002·22 cites·15 claims
- 1583US6498185B1Ortho-anthranilamide derivatives as anti-coagulantsBERLEX LAB·Filed 2000·Granted Dec 24, 2002·14 cites·17 claims
- 1682US7323480B2Substituted triazoles as modulators of PPAR and methods of their preparationMETABOLEX INC·Filed 2005·Granted Jan 29, 2008·6 cites·21 claims
- 1779US7622491B2Modulators of PPAR and methods of their preparationMETABOLEX INC·Filed 2005·Granted Nov 24, 2009·4 cites·57 claims
- 1879US7371888B2α-(Trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agentsMETABOLEX INC·Filed 2005·Granted May 13, 2008·3 cites·10 claims
- 1978US9737537B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·1 cites·2 claims
- 2078US6747031B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Jun 8, 2004·6 cites·10 claims
- 2173US6670473B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Dec 30, 2003·3 cites·8 claims
- 2272US7642358B2Substituted phenylacetic acidsMETABOLEX INC·Filed 2006·Granted Jan 5, 2010·1 cites·24 claims
- 2372US6541476B1Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2000·Granted Apr 1, 2003·3 cites·9 claims
- 2470US7078421B2Substituted phenylacetic acidsMETABOLEX INC·Filed 2003·Granted Jul 18, 2006·4 cites·31 claims
- 2570US6841674B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Jan 11, 2005·2 cites·6 claims
- 2667US9925189B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2017·Granted Mar 27, 2018·0 cites·2 claims
- 2766US6887865B2N-heterocyclic derivatives as NOS inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2002·Granted May 3, 2005·1 cites·8 claims
- 2866US6849739B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Feb 1, 2005·1 cites·2 claims
- 2966US6846829B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Jan 25, 2005·1 cites·18 claims
- 3064US8921350B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2013·Granted Dec 30, 2014·0 cites·4 claims
- 3163US2025034196A1Ester derivatives of n4-hydroxycytidine and use thereofSUZHOU SPRING SEA BIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 3261US8975258B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2012·Granted Mar 10, 2015·0 cites·22 claims
- 3360US7268140B2Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2005·Granted Sep 11, 2007·0 cites·11 claims
- 3459US2010087468A1Modulators of ppar and methods of their preparationMETABOLEX INC·Filed 2009·Application pending·0 cites
- 3558US2009093650A1Resolution of alpha-(phenoxy)phenylacetic acid derivatives with naphthyl-alkylaminesMETABOLEX INC·Filed 2008·Application pending·0 cites
- 3657US2008287441A1Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agentsMETABOLEX INC·Filed 2008·Application pending·0 cites
- 3756US6977258B2Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2003·Granted Dec 20, 2005·0 cites·19 claims
- 3856US6972290B2Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2003·Granted Dec 6, 2005·0 cites·23 claims
- 3956US2015239881A1Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2015·Application pending·0 cites
- 4055US6864263B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Mar 8, 2005·0 cites·11 claims
- 4155US6841673B2N-heterocyclic derivatives as nos inhibitorsBERLEX LAB·Filed 2002·Granted Jan 11, 2005·0 cites·1 claims
- 4254US2008108630A1Substituted triazoles as modulators of ppar and methods of their preparationMETABOLEX INC·Filed 2007·Application pending·0 cites
- 4353US6573266B1Piperazine derivatives and their use as anti-inflammatory agentsSCHERING AG·Filed 2000·Granted Jun 3, 2003·0 cites·4 claims
- 4452US2010216827A1Aryl gpr120 receptor agonists and uses thereofMETABOLEX INC·Filed 2009·Application pending·0 cites
- 4551US2009270404A1Oxymethylene aryl compounds and uses thereofMETABOLEX INC·Filed 2009·Application pending·0 cites
- 4650US2011294836A1Aryl gpr119 agonists and uses thereofSONG JIANGAO·Filed 2009·Application pending·0 cites
- 4749US6864368B2N-heterocyclic derivatives as NOS inhibitorsBERLAX LAB INC·Filed 2002·Granted Mar 8, 2005·0 cites·1 claims
- 4847US8846675B2N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersMA JINGYUAN·Filed 2012·Granted Sep 30, 2014·0 cites·22 claims
- 4946US2004039053A1Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemiaFiled 2001·Application pending·0 cites
- 5041US2006014785A1Bicyclic, substituted triazoles as modulators of ppar and methods of their preparationMETABOLEX INC·Filed 2005·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →